Navigation Links
Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
Date:3/20/2009

PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, March 20 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) announces that it has filed a lawsuit in the U.S. District Court of the Southern District of New York against Mylan Inc., Mylan Pharmaceuticals Inc. and Matrix Laboratories Limited (collectively "Mylan") for infringement of Shire's patent: U.S. Patent No. 5,968,976 ("'976 Patent").

The lawsuit was filed in response to an Abbreviated New Drug Application ("ANDA") filed by Mylan seeking FDA approval to market and sell generic versions of Shire's 500 mg, 750 mg, and 1 g FOSRENOL(R) (lanthanum carbonate) products.

Under the Hatch-Waxman Act, because Shire filed its patent infringement lawsuit within 45 days of receiving Mylan's Paragraph IV notification letter, the FDA must refrain from approving Mylan's ANDA for 30 months, or until a District Court decision finding that the patent is invalid or not infringed, whichever occurs earlier. The stay on generic approval will expire on April 26, 2012 unless terminated earlier.

Shire has asserted the '976 patent based upon information provided to it by Mylan. Shire will continue to evaluate the situation throughout the litigation and will take all necessary actions to protect its rights to the fullest extent possible. Shire has a robust patent estate and is confident that it will protect the FOSRENOL franchise.

Shire PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents
2. Shire Announces Opening of Office in Japan
3. Shire to Enter European ADHD Market With the Acquisition of EQUASYM(R) IR and XL
4. Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion
5. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
6. Shire plc: Change to Directors Details
7. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
8. Shires New Product Portfolio Delivers Strong Quarterly Performance
9. Change of Name to Shire plc
10. Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document
11. Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Joins with State Biotech Leaders to Develop ... and Development while Boosting Rhode Island,s Growing ... PROVIDENCE, R.I., Dec. 14 Several ... research, medicine and biotechnology gathered today at ... the importance of medical innovation in Rhode ...
(Date:12/14/2009)... Dec. 14 Decision Resources, one of ... pharmaceutical and healthcare issues, finds that, owing to ... fibrillation drug market will increase more than sevenfold ... in 2018 in the United States, France, Germany, ... The new Pharmacor report entitled Atrial Fibrillation ...
(Date:12/11/2009)... Colo., December 10, 2009 miRagen Therapeutics, Inc., ... by developing innovative microRNA-based therapeutics for cardiovascular and ... demonstrating that microRNA-206 (miR-206) plays a crucial role ... or Lou Gehrig,s disease) and in neuromuscular synaptic ... the December 11 issue of the journal ...
(Date:12/11/2009)... -- Marrone Bio Innovations (MBI) today announces 2 ... Chris Hildreth joined MBI as Senior Vice President ... all commercial aspects of the company, including sales, ... (Ray) Lam joined MBI as Vice President of ... in scaling its broad pipeline of products to ...
Breaking Biology Technology:Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3
(Date:12/11/2009)... GETTYSBURG, PAAs consumer demand for premium fruit increases, ... fruit to market. And to boost their bottom ... that can increase fruit quality while reducing labor ... by growers to produce larger, healthier fruit, is ... a significant impact on fruit production overhead, and, ...
(Date:12/11/2009)... cell manage to identify and degrade the diverse types ... serious diseases? The researchers Sabine C. Horn, Professor Thomas ... the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, ... puzzle. In an enzyme complex that plays a critical ... a scaffold regulating the identification and disposal of various ...
(Date:12/11/2009)... the deep ocean,s temperature variability and circulation system could ... deep ocean is affected more by surface warming than ... predictions of factors such as sea level rise and ... also been found to result in a more vigorous ... faster transport of large quantities of warm water, with ...
Breaking Biology News(10 mins):Horizontal string trimmer reduces labor costs, increases peach size 2MDC researchers identify a scaffold regulating protein disposal 2New discoveries could improve climate projections 2Webcast of QIAGEN N V s 28Nasdaq 3A QGEN 29 Second Quarter 2009 Financial Results Call Set for August 11 13355 1Webcast of QIAGEN N V s 28Nasdaq 3A QGEN 29 Second Quarter 2009 Financial Results Call Set for August 11 13355 2Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 1Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 2Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 4Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 5Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 6Landauer Inc Reports Fiscal 2009 Third Quarter Results 53600 1Landauer Inc Reports Fiscal 2009 Third Quarter Results 53600 2Landauer Inc Reports Fiscal 2009 Third Quarter Results 53600 3Landauer Inc Reports Fiscal 2009 Third Quarter Results 53600 4Landauer Inc Reports Fiscal 2009 Third Quarter Results 53600 5Landauer Inc Reports Fiscal 2009 Third Quarter Results 53600 6Landauer Inc Reports Fiscal 2009 Third Quarter Results 53600 7Landauer Inc Reports Fiscal 2009 Third Quarter Results 53600 8Landauer Inc Reports Fiscal 2009 Third Quarter Results 53600 9
... drug abusers from relapsing, researchers at the University of ... Everitt, was able to reduce drug-seeking behaviours in rats ... and memory during the recall of drug-associated memories. ... Council, was reported in the 13 August issue of ...
... species around the world are a sign of a ... ilk, according to researchers from the University of California, ... in the journal Proceedings of the National Academy ... of amphibians and other plant and animal species add ...
... University of California, Davis, law professor Keith Aoki ... plants over the past several decades and speculates ... resources remain freely available across national borders to ... Controversies and Cases on Plant Genetic Resources and ...
Other Biology News:'Erasing' drug-associated memories may stop drug addiction relapses 2Dying frogs sign of a biodiversity crisis 2Dying frogs sign of a biodiversity crisis 3
Rabbit polyclonal to Staphylococcus Enterotoxin A (HRP) ( Abpromise for all tested applications)....
... with a modular approach to instrument control, ... Plus NDS family provides modular software components ... management, giving you the flexibility to choose ... now and that can grow as your ...
... Best: DASGIPs Process Control integrates Process ... comprehensive documentation for cultivation processes. A ... pH, dissolved oxygen, temperature and agitation ... Profiles, e.g. constant or scheduled media ...
... Microarrays designed for immunological studies, vaccine ... the flexible and powerful Paraflo microfluidic ... available as part of our comprehensive ... Custom Probe Content Probe content ...
Biology Products: